STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
公司代码STAA
公司名称STAAR Surgical Co
上市日期Feb 24, 1992
CEOFarrell (Stephen C)
员工数量1157
证券类型Ordinary Share
年结日Feb 24
公司地址1911 Walker Ave
城市MONROVIA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编91016
电话16263037902
网址https://www.staar.com/
公司代码STAA
上市日期Feb 24, 1992
CEOFarrell (Stephen C)